̽»¨¾«Ñ¡

Fang Fang (R01/Prime) - Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden

Camilla Svensson (CDMRP/Sub) - Fc gamma receptor signaling: a new pathway for sustained neuropathic pain

Samir EL Andaloussi (CDMRP/Prime) - Muscle-Targeted Cell-Penetrating Peptides for Delivery of Cas9-RNPs and Modified mRNA to Dystrophic Muscle

Helena Ledmyr (Office of Naval Research) – CSP – The 10th Neuroinformatics Congress of the International Neuroinformatics Coordinating Facility (INCF)

Barbara Canlon (CDMRP/Prime) – Chronopharmacological Interventions for the Successful Treatment of Noise-Induced Hearing Loss.

Theresa Vincent (CDMRP/Sub) – Targeting Breast Cancer Metastasis through Selective Inhibition of RNA Polymerase I.

Anna Norrby-Teglund (R01/Sub) Assays for acceleration: from fit-for-purpose models to scalable assays of broad systemic and mucosal protection against all strains of Group A Streptococcus

• Malin Ernberg (UC2/Sub) Comprehensive functional phenotyping of trigeminal neurons innervating temporomandibular joint (TMJ) tissues in male-female and aged mice primates and humans with and without TMJ disorders (TMJD)
• Josefin Särnholm (P30/Sub) Columbia Roybal Center for fearless behavior change
• Rickard Sandberg (U01/Sub) Comprehensive single-cell atlas of the developing mouse brain
• Sten Linnarsson and Rickard Sandberg (UM1/Sub) Functionally guided adult whole brain cell atlas in human and NHP

• Elisabet Svenungsson (R01/Sub) -Role of mitochondria in SLE and its cardiovascular complications
• Carina King (R21/Sub) - Development and implementation of pediatric mobile phone reflectance pulse oximeters and a hypoxemia surveillance system in South Africa
• Jan Albert (R01/Sub) -  Next-generation algorithms using multiple biomarkers for precise estimation of HIV infection duration and population level incidence
• Rikard Holmdahl (R15/Sub) - Autoantibody modulation of cartilage turnover in rheumatoid arthritis
• Benjamin Murrell (R01/Sub) - HIV-1 dynamics and evolution during trispecific broadly neutralizing antibody therapy
• Sara Hagg (R01/Prime) - Repurposing drugs for Alzheimer´s disease using a reverse translational approach
• Alek Erickson (F32/Prime) - Signaling mechanisms underlying neural crest cell fate decisions
• Mikael Karlsson (R01/Sub) - Engaging immunosuppressive myeloid cells in the TME for the treatment of pancreatic cancer
• Ulrika Marklund (R01/Sub) - Neurobiology of Intrinsic Primary Afferent Neurons
• Petter Brodin (U01/Sub) - Enhancing immunity to malaria in young children with effective chemoprevention
• Ingrid Lundberg (R21/Sub) - Extracellular mitochondria in Inclusion Body Myositis
• Gunilla Karlsson Hedestam (P01) â€“ HIV vaccine research and design

• Lars Terenius (R01/Prime) – Drug targeting the dynamics of opioid systems in alcohol dependence
• Anna Marseglia (R24/Sub) – Developing a biological marker of cognitive reserve with deep learning from multimodal structural MRI
• Nina Bohm-Starke (R21/Sub) – Risk of vulvodynia due to immune-related health events throughout the life course
• Yi Lu (R01/Sub) – A Trans-Nordic Study of Extreme Major Depression
• Sarah Bergen (R01/Prime) – A comparison of environmental and genetic risks for schizophrenia and bipolar disorder: A Swedish national study
• Ivan Nalvarte (R01/Prime) – Understanding the role of menopause and estrogen receptor activation for Alzheimer's disease risk
• Elizabeth Arkema (R01/Sub) – Can hydroxychloroquine prevent preeclampsia and preterm delivery in lupus pregnancy?

• Sara Öberg (R01/Sub) – Maternal use of prescribed opioid analgesics and risk of adverse offspring outcomes
• Gunilla Karlsson Hedestam (P51/Sub) – Support of Yerkes National Primate Research Center
  Karl Eriksson (U01/Sub) – STABILITY 2: ACL Reconstruction +/- Lateral Tenodesis with Patellar vs. Quad Tendon
• Sven Cnattingius (R21/Sub) – Prenatal and Neonatal Risk Factors for Adverse Neurodevelopmental Outcomes in Childhood and Early Adulthood
• Gunilla Karlsson Hedestam (UM1/Sub) – Consortium for HIV/AIDS Vaccine Development
• Cecilia Magnusson (R01/Sub) – Maternal epilepsy, antiepileptic drug use during pregnancy, and risk of autism
• Benjamin Murrell (UM1/Sub) – HVTN Laboratory Center

Sarah Bergen (R21/Prime) – Schizophrenia Comorbidities: Common Genes and Clusters

• Tatiana Deliagina (R01/Sub) - Neural Mechanisms of Locomotion Evoked by Epidural Stimulation of the Spinal Cord
• Sara Öberg (R01/Sub) - Long-term Impact of Fertility Treatment Study
• Johan Grunewald (R01/Sub) – T cell epitopes in sarcoidosis
• Rickard Sandberg (R01/Sub) – Deciphering the building blocks of hippocampal circuits
• Maria Sabater Lleal (R01/Sub) – Population genomic variation, functional biology, and the risk of venous thrombosis
• Rickard Sandberg (U19/Sub) – A comprehensive whole-brain atlas of cell types in the mouse
• Sten Linnarsson (U01/Sub) – A multimodal atlas of human brain cell types
• Barbara Canlon (R56/Prime) – Circadian regulation of glucocorticoid-dependent inflammation in noise-induced synaptopathy
• Michael Yi Bonner (F31/Prime) – Redox modulation - Impact on Tumor Growth and Therapeutic Anticancer Efficacy
• Ivanka Savic-Berglund (R01/Sub) – Gender identity and own body perception implications for the neurobiology of gender dysphoria
• Gunilla Karlsson Hedestam (U01/Sub) – Immunoglobulin gene diversity in an African population and impact on antibody function in HIV infection

• Ahmed Elewa (F32/Prime) – Discovering signature genes and developing expression markers for blastema cells
• David Mataix-Cols (R01/Sub) – OCD: Novel Comparative Genomic Approaches to Identify Disease and Treatment Mechanisms.
• Elias Arnér (R21/Sub) - Redox regulation in the hepatostat.
• Fredrik Wiklund (R01/Sub) – The Genetic Basis of Aggressive Prostate Cancer: The Role of Rare Variation.
• Konstantinos Meletis (R21/Sub) – Development of a whole-brain cellular mapping approach in a genetic model of autism and intellectual disability.
• Nancy Pedersen (R56/Sub) – Gene-Environment Interplay of Social contexts and Aging-Related Outcomes.
• Ujjwal Neogi (R01/Sub) – Reverse Transcriptase Multi-Class Drug Resistance and Rilpivirine Susceptibility in Diverse HIV-1 Subtypes.

2020

• Karin Loré (Prime) – COVID-19: NHP Study of Novavax nanoparticle at Karolinska.
• Anna Smed Sörensen – (Prime) - COVID-19: blood and airway disease in Sweden.
• Karin Loré (Prime) –  Immunogenicity study of CureVac’s mRNA vaccine for Covid-19 in rhesus macaques.
• Helena Lindgren – Maternal and child health-care in Sub-Saharan African countries.

2018

Karin Loré (Prime) – Analyse the immune responses elicited by novel mRNA-based vaccines. 

2017

Karin Loré (Sub) – Structure Based Immunogen Design at UWIPD.

2015

• Björn Westrup
• Tobias Alfvén
• Antonio Gigliotti Rothfuchs

2015 

Jeffrey Modell Foundation: Lennart Hammarström (Sub)

Patient-Centered Outcomes Research Institute (PCORI): Fredrik Piehl (Prime) – Rituximab in Multiple Sclerosis: A Comparative Study on Effectiveness, Safety, and Patient-Reported Outcomes.

2016

CHDI Foundation Inc: Christer Halldin

The Myositis Association: Ingrid Lundberg

The Vallee Foundation: Rickard Sandberg (Vallee Scholar) – The nature of allelic gene expression in vivo.